Is This Really The Last Week?

Quote






























Anonymous said:
April 23rd


http://financialedge.investopedia.c...-Companies-With-Expiring-Patents-In-2011.aspx
Click to expand...

What does 1+1-2= ???

Eli Lilly and Company - Zyprexa
Developed to treat schizophrenia, and bipolar and treatment-resistant depression, Eli Lilly's drug, Zyprexa, is slated for patent expiration in April 2011. As a result, in 2009, the company began streamlining measures to prepare for the rush of generics to the market, including cutting 5,500 jobs and restructuring internally to speed up new drug launches. But, in light of the cost-cutting measures, analysts anticipate that earnings growth may improve over the next three to five years.
 










































Anonymous said:
Generics can not start selling their version until October. So the patent may expire but Lilly still has a few months until zero profit hour.
Click to expand...

The real question is, when does the stock tank in anticipation? Then, investors will want to see some blood to preserve their big fat dividend (which is excessive imho).

Does anyone know who is first to file for the generic Zydis?
 






Anonymous said:
The real question is, when does the stock tank in anticipation? Then, investors will want to see some blood to preserve their big fat dividend (which is excessive imho).

Does anyone know who is first to file for the generic Zydis?
Click to expand...

The stock price has had all of the patent expirations built in for a long time. This is not a secret to analysts.
 






Anonymous said:
The stock price has had all of the patent expirations built in for a long time. This is not a secret to analysts.
Click to expand...

Are you sure about that?

I read a lot of stock analysis, and Lilly is a real darling simply because dividends have been consistently raised for many years, despite the reality of the future financial ruin.

Take a look sometime. The venerable Motley Fool, for example, calls Lilly a "Dividend Aristocrat" - as if that is the sole criterion for picking a stock - and it is to many.
 






Anonymous said:
Are you sure about that?

I read a lot of stock analysis, and Lilly is a real darling simply because dividends have been consistently raised for many years, despite the reality of the future financial ruin.

Take a look sometime. The venerable Motley Fool, for example, calls Lilly a "Dividend Aristocrat" - as if that is the sole criterion for picking a stock - and it is to many.
Click to expand...

The party will last as long as there are bodies to fling out the door that offset the losses. What I think well be the most revealing is if they keep paying severance or if the next waves start getting less and less.
 






Anonymous said:
The party will last as long as there are bodies to fling out the door that offset the losses. What I think well be the most revealing is if they keep paying severance or if the next waves start getting less and less.
Click to expand...

Sure, cut off a toe to spare the foot.

Maybe the company foot can survive the loss of one two, possibly two, but beyond that walking is going to difficult or impossible.

Maybe, that is the reason for having "partners" a la FIPNET - to keep the gimp upright.
 






Anonymous said:
Sure, cut off a toe to spare the foot.

Maybe the company foot can survive the loss of one two, possibly two, but beyond that walking is going to difficult or impossible.

Maybe, that is the reason for having "partners" a la FIPNET - to keep the gimp upright.
Click to expand...

Through FIPNet, the "gimp' is transformed into the Human Centipede, all while enjoying unstainable dividends going forward....as Derica.
 






Top Bottom
Back
Quote